Qingdao Saber Technology Pharmaceutical: difference between revisions
Diff·revision 24 → 25·19:13, 29 Sep 2025
Difference between revision 24 and revision 25 of Qingdao Saber Technology Pharmaceutical. 1 line changed; the page grew by 82 bytes.
| Revision 24 — 17:25, 21 Sep 2025 ArchiveBot (talk) bot: normalise citation format 7,410 bytes ±0 | Revision 25 — 19:13, 29 Sep 2025 BlindSampleBrid (talk) add {{refimprove}}7,492 bytes +82 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=Two organisations, one city, similar names}} | |
| 21 | 22 | ||
| 22 | '''Qingdao Saber Technology Pharmaceutical''' (trading as '''QST'''; qingdaosabertechnology.com) is a research-compound supplier trading as QST from Qingdao, Shandong, China, incorporated in 2017, supplying research peptides, SARMs and raw materials with batch documentation.{{r|registry,selfpub}} | 23 | '''Qingdao Saber Technology Pharmaceutical''' (trading as '''QST'''; qingdaosabertechnology.com) is a research-compound supplier trading as QST from Qingdao, Shandong, China, incorporated in 2017, supplying research peptides, SARMs and raw materials with batch documentation.{{r|registry,selfpub}} |